Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease

Summary

The primary objective of this study is to show that consistent use of Systane PRO over a 30 period will significantly improve the signs and symptoms of Dry Eye Disease and decrease patients' ocular surface disease index score for patients diagnosed with mild-moderate (DED).

Timeline

Start

2025-11-01

Primary completion

2026-02-01

Completion

2026-02-01

Drugs

Indications